- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming TRAIL Resistance for Glioblastoma Treatment
Authors
Keywords
-
Journal
Biomolecules
Volume 11, Issue 4, Pages 572
Publisher
MDPI AG
Online
2021-04-15
DOI
10.3390/biom11040572
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy
- (2021) Deepika Singh et al. Future Oncology
- TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
- (2020) Hassan Dianat-Moghadam et al. PHARMACOLOGICAL RESEARCH
- Death Receptors and Their Ligands in Inflammatory Disease and Cancer
- (2020) Alessandro Annibaldi et al. Cold Spring Harbor Perspectives in Biology
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- Management of glioblastoma: State of the art and future directions
- (2020) Aaron C. Tan et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cell Lineage-Based Stratification for Glioblastoma
- (2020) Zilai Wang et al. CANCER CELL
- TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway
- (2020) Ilknur Sur-Erdem et al. NEUROLOGICAL RESEARCH
- TRAIL therapy and prospective developments for cancer treatment
- (2020) Bindu Thapa et al. JOURNAL OF CONTROLLED RELEASE
- Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis
- (2019) Joseph A. Ross et al. Cell Death & Disease
- The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
- (2019) Erik Ladomersky et al. Frontiers in Pharmacology
- Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
- (2019) Zhi-Chuan Zhu et al. Cell Death & Disease
- PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism
- (2019) Santiago Serrano-Saenz et al. Cell Death & Disease
- Therapy for glioblastoma: is it working?
- (2019) Edward D. Zanders et al. DRUG DISCOVERY TODAY
- Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival
- (2019) Andrea Gras Navarro et al. Cancers
- Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
- (2019) Mohammed I. Y. Elmallah et al. Cancers
- Repurposing quinacrine for treatment-refractory cancer
- (2019) Derek B. Oien et al. SEMINARS IN CANCER BIOLOGY
- Circulating biomarkers in patients with glioblastoma
- (2019) Juliana Müller Bark et al. BRITISH JOURNAL OF CANCER
- Molecular targeted therapy of glioblastoma
- (2019) Emilie Le Rhun et al. CANCER TREATMENT REVIEWS
- Safety of high-dose ivermectin: a systematic review and meta-analysis
- (2019) Miriam Navarro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Potential Pharmacological Inhibitors Of Pim Kinase Under Clinical Trials
- (2018) Gomathi Priya Jeyapal et al. Anti-Cancer Agents in Medicinal Chemistry
- Developing TRAIL/TRAIL death receptor-based cancer therapies
- (2018) Xun Yuan et al. CANCER AND METASTASIS REVIEWS
- Cell death-based treatment of glioblastoma
- (2018) Simone Fulda Cell Death & Disease
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
- (2018) Sainan An et al. EBioMedicine
- Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
- (2018) Frank A. Lincoln et al. Cell Death & Disease
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis
- (2017) Deepak Bhere et al. NEURO-ONCOLOGY
- Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells
- (2017) Xiao Zhang et al. NUCLEIC ACIDS RESEARCH
- Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy
- (2017) Pi Chu Liu et al. PLoS One
- KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL
- (2017) Ibrahim Cagri Kurt et al. Cell Death & Disease
- A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
- (2017) Isabel Arrillaga-Romany et al. Oncotarget
- miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
- (2017) Shan-shan Wang et al. Molecular Therapy-Nucleic Acids
- ONC201: a new treatment option being tested clinically for recurrent glioblastoma
- (2017) Marie D. Ralff et al. Translational Cancer Research
- TIC10/ONC201—a potential therapeutic in glioblastoma
- (2017) Georg Karpel-Massler et al. Translational Cancer Research
- Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme
- (2016) Filiz Senbabaoglu et al. CANCER BIOLOGY & THERAPY
- Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers
- (2016) Pelin Erkoc et al. MACROMOLECULAR BIOSCIENCE
- Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery
- (2016) Xinyi Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo
- (2016) Georg Karpel-Massler et al. Oncotarget
- Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide
- (2016) Birgit C. Weyhenmeyer et al. Oncotarget
- Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions
- (2015) Avi Ashkenazi JOURNAL OF CLINICAL INVESTIGATION
- Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer
- (2015) Sean P. Cullen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma
- (2015) Kui Wang et al. Advanced Healthcare Materials
- Targeting DNA damage response in cancer therapy
- (2014) Noriko Hosoya et al. CANCER SCIENCE
- PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD
- (2014) Fresia Pareja et al. MOLECULAR CANCER RESEARCH
- Salinomycin Potentiates the Cytotoxic Effects of TRAIL on Glioblastoma Cell Lines
- (2014) Alessia Calzolari et al. PLoS One
- Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin
- (2013) Dae-Hee Lee et al. ANTI-CANCER DRUGS
- Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
- (2013) Á. C. Murphy et al. APOPTOSIS
- Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
- (2013) Bryant England et al. TUMOR BIOLOGY
- Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation
- (2012) Weiyang He et al. Autophagy
- MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
- (2012) Daina Skiriute et al. BMC CANCER
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
- (2012) Changyou Zhan et al. JOURNAL OF CONTROLLED RELEASE
- Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP
- (2012) A Bangert et al. ONCOGENE
- Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1
- (2012) A Fassl et al. ONCOGENE
- Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells
- (2012) C Quintavalle et al. ONCOGENE
- ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
- (2012) S Cristofanon et al. Cell Death & Disease
- A20 Ubiquitin Ligase–Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma
- (2012) Anita C. Bellail et al. Cancer Discovery
- Nanotechnological advances for the delivery of CNS therapeutics
- (2011) Ho Lun Wong et al. ADVANCED DRUG DELIVERY REVIEWS
- Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis
- (2011) Ling Qi et al. APOPTOSIS
- Cisplatin Restores TRAIL Apoptotic Pathway in Glioblastoma-Derived Stem Cells through Up-regulation of DR5 and Down-regulation of c-FLIP
- (2011) Lijuan Ding et al. CANCER INVESTIGATION
- Targeting apoptosis pathways in glioblastoma
- (2011) Günter Eisele et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis
- (2011) T. Unterkircher et al. CLINICAL CANCER RESEARCH
- Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
- (2011) Xiaobing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes
- (2011) Liangran Guo et al. JOURNAL OF CONTROLLED RELEASE
- Bortezomib Sensitizes Malignant Human Glioma Cells to TRAIL, Mediated by Inhibition of the NF- B Signaling Pathway
- (2011) E. P. Jane et al. MOLECULAR CANCER THERAPEUTICS
- Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor–related apoptosis-inducing ligand and induces an alternative cell death pathway
- (2011) Christian E. Badr et al. NEURO-ONCOLOGY
- ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1
- (2011) Bryan W. Day et al. NEURO-ONCOLOGY
- IRES-mediated translation of cellular messenger RNA operates in eIF2α- independent manner during stress
- (2011) Nehal Thakor et al. NUCLEIC ACIDS RESEARCH
- Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells
- (2011) C Jennewein et al. ONCOGENE
- Ubiquitin-Specific Protease 8 Links the PTEN-Akt-AIP4 Pathway to the Control of FLIPSStability and TRAIL Sensitivity in Glioblastoma Multiforme
- (2010) Amith Panner et al. CANCER RESEARCH
- Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis
- (2010) Ting-Kuang Niu et al. FEBS LETTERS
- Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
- (2010) Surasak Phuphanich et al. JOURNAL OF NEURO-ONCOLOGY
- Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro
- (2010) Jian Chen et al. TUMOR BIOLOGY
- Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer
- (2009) Bodvaël Pennarun et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death
- (2009) Vanesa Martín et al. CANCER LETTERS
- A Novel PTEN-Dependent Link to Ubiquitination Controls FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme
- (2009) A. Panner et al. CANCER RESEARCH
- DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas
- (2009) Anita C. Bellail et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Identification of a novel pro-apopotic function of NF-κB in the DNA damage response
- (2009) Sabine Karl et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells
- (2009) J. F. Dorsey et al. MOLECULAR CANCER THERAPEUTICS
- The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP
- (2009) M.D. Siegelin et al. NEUROCHEMISTRY INTERNATIONAL
- Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-κB inhibition
- (2008) Johannes U. Ammann et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies
- (2008) Gregory J. Kubicek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started